Baccharis flabellata
Baccharis flabellata · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Baccharis flabellata is a significant botanical species that has garnered increasing interest in pharmacological research. Recent investigations have focused on evaluating the therapeutic potential of its various chemical constituents. Specifically, studies have examined the biological activities of different plant extracts derived from this species. A primary area of focus involves exploring its notable antinociceptive properties in experimental models. Understanding these mechanisms provides valuable insights into the plant's potential as a natural source for pain management.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Asia-Tropical
- Plant Parts
- Not available
Classification
Taxonomy
Baccharis flabellata is a unique botanical specimen belonging to the kingdom Plantae. Within this vast kingdom, it is specifically categorized under the class Equisetopsida. This plant falls into the order Asterales, showcasing its evolutionary connection to diverse flowering species. It further belongs to the prominent family Asteraceae, a group known for its distinctive floral structures. Ultimately, this species is defined by its placement within the genus Baccharis.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Baccharis |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Baccharis flabellata is a notable plant species found primarily throughout the regions of Southern America. Its distribution extends across the southern reaches of the continent, specifically within the territories of Southern South America. In Argentina, the plant can be located in both the northeast and northwest regions of the country. Additionally, its presence is well-documented within the borders of Uruguay. This geographic range highlights the plant's ability to thrive in various environments across these southern landscapes.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Baccharis flabellata is characterized by its distinct shrub growth form. This hardy plant is entirely self-supporting, allowing it to maintain its structure independently in its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Baccharis flabellata has demonstrated significant antinociceptive activity through the study of its neo-clerodane diterpene extracts. Research indicates that both summer and winter extracts possess these pain-relieving properties, though the summer harvests are notably more potent. This biological effect is primarily attributed to two specific compounds, the diene-acid clerodane (DAC) and its dimer (DACD). Investigations reveal that these substances function by interacting with opioid receptors, with DACD exhibiting a much stronger effect than DAC. Ultimately, these findings suggest a molecular mechanism similar to salvinorin A, offering valuable insights for the development of new κ-opioid receptor inhibitors.
Compounds
Conditions
Baccharis flabellata exhibits significant antinociceptive effects through extracts obtained during both summer and winter seasons. The plant's ability to treat pain is primarily attributed to the neo-clerodane diterpenes DAC and its dimer, DACD. Research demonstrates that these compounds exert their effects by acting on opioid receptors, with DACD showing nearly twice the potency of DAC in hot-plate tests. Molecular modeling further reveals that DACD forms stronger interactions with κ-opioid receptors, which explains its heightened affinity and superior analgesic activity. Consequently, these findings suggest that the bioactive components of Baccharis flabellata function through a mechanism similar to salvinorin A.
Preparations
Baccharis flabellata is prepared as extracts to investigate their potential antinociceptive properties. Researchers analyzed two distinct types of these preparations, one obtained during the summer and another during the winter. The study revealed that both forms of the plant extract exhibit strong effects in reducing pain sensation. Notably, the extracts produced during the summer season demonstrated significantly higher biological activity than the winter versions. These specific preparations allow for the isolation of neo-clerodane diterpenes, which are responsible for interacting with opioid receptors.